Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4). Cyclin-dependent kinase inhibitor 2A interacts strongly with cdk4 and cdk6. It belongs to the cdkn2 family of cyclin-dependent kinase inhibitors, and plays role in cyclins and cell cycle regulation.CDKN2A acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This interaction inhibits CDKs binding to cyclins D and phosphorylation of the retinoblastoma protein. Defects in CDKN2A are the cause of numerous cancers such as melanoma and astrocytoma.
p16 Polyclonal Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been tested with WB and ELISA. And Abbkine suggested starting dilutions are as follows: WB: 1:500-1:2000, ELISA: 1:10000. Not yet tested in other applications.
CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. It applies to WB and ELISA experiments. It's convenient to choose this product.
2017年1月24日星期二
p16 Polyclonal Antibody Review
订阅:
博文评论 (Atom)
没有评论:
发表评论